Kings Path Partners’s Boston Scientific BSX Stock Holding History

Kings Path Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$30.8K	Hold	706	–	–	0.01%	194
2026 Q2	$30.1K	Hold	706	–	–	0.01%	199
2026 Q1	$44.3K	Hold	706	–	–	0.02%	168
2025 Q4	$67.3K	Hold	706	–	–	0.02%	155
2025 Q3	$68.9K	Hold	706	–	–	0.03%	149
2025 Q2	$75.8K	Hold	706	–	–	0.03%	137
2025 Q1	$71.2K	Hold	706	–	–	0.03%	134
2024 Q4	$63.1K	Hold	706	–	–	0.03%	166
2024 Q3	$59.2K	Hold	706	–	–	0.02%	171
2024 Q2	$54.4K	Buy	+706	New	+$51.7K	0.03%	157

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Kings Path Partners's BSX Position: Q3 2026 in Review

Kings Path Partners held its Boston Scientific (BSX) position steady in Q3 2026 at 706 shares worth $30.8K. The position accounts for 0.01% of the portfolio, ranked #194.

Kings Path Partners first reported a position in BSX in Q2 2024 and has held it in 10 quarters since. The position peaked at $75.8K in Q2 2025. 478 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Kings Path Partners held 706 shares of Boston Scientific worth $30.8K as of Q3 2026.
Kings Path Partners left its Boston Scientific share count unchanged in Q3 2026.
Boston Scientific made up 0.01% of Kings Path Partners's portfolio in Q3 2026, its #194 holding.
Kings Path Partners first reported a position in Boston Scientific in Q2 2024 and has held it in 10 quarters since.
Kings Path Partners's Boston Scientific position peaked at $75.8K in Q2 2025.
478 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Kings Path Partners's 13F filing for Q3 2026, filed 21 Oct 2026.